Cardiovascular Dyslipidaemia Flashcards
Statins
- example
- moa
- SE
- precautions
Example: atorvaatatin, pravastatin, simvastatin
Moa: competitively inhibit hmg-coa reductase, rate limiting step in cholesterol synthesis, increase hep cholesterol uptake, reduce concentration of total cholesterol, LDL and triglyceride,
SE: myalgia, derange LFT, myopathy rhabdomyolysis, renal failure and hepatitis, pancreatitis, gallstones
Precautions: withhold serious illness, increase risk of myopathy, rhabdomyolysis, rf (which increase myopathy and rhabdomyolysis)
Start low dose, monitor rf and ck, ck, LFT, EUC
Atorvaatatin and simvastatin is better and cheaper then pravastatin
Bile acid binding resins
- ‘example
- moa
- SE
Example- cholestyramine, cholestipol
Moa- bind bile acids in intestinal lumen, prevent reabsorption, and increase bile acid excretion in faeces -> increase synthesis of bile acid therefore increase demand for cholesterol therefore increase LDL uptake and remove from plasma
SE: GIT, increase trigs (exacerbate hypertriglyceridaema), steatohoea, malnutrition, malabsorption of fat soluable vitamin, constipation, worsen diverticular disease
Vibrates
- example
- moa
- SE
Example - gemfibrozil, fenofibrate
Moa- activiate peroxisome proliferator activated nuclear receptor and modulate lipoprotein synthesis and catabolis, reduce plasma triglyceride,
Variable effect on LDL and increase HDL
SE: GIT distrubance, increase creatinine, photosensitive, cholestatic jaundice, gallstones, anaemia, myopathy, rhabdomyolysis
Ezetimibe
- moa
- se
Moa - reduce absorption of dietary and biliary cholesterol by inhibiting its transport across the intestinal wall, therefore increase demand for cholesterol and increase LDL uptake
SE: headache, diahrrhoea, dearranged LFT, myalgia, allergy, pancreatitis, myopathy, raise ck
Nicotinic acid
- moa
- SE
- cautions
Moa - suppress fatty acid and release from pheripheral tissue
SE: vasodilate (inhibit if take aspirin before), face and neck flush, hypotension, raise ck, LFT , macular edema, rf
Watch out for rf and take with food
Rationale
How to start treatment
When to start
Drug choice
Rationale - reduce atherosclerosis, improve survival and risk of mi/stroke, reduce cardiovascular mortality, prevent pancreatitis
Starting treatment - measure fasting plasma lipid profile, consider cv status, rf, treat secondary cause like obesity, diabetes, hypothyroidism, nephrotic syndrome, alcohol
Non pharm - weight reduce, diet change, exercise, reduce smoke and alcohol, dietitian,
Start when : high risk (pre exist IHD),
Drug choice:
Statins most effective, well tolerated , reduce mortality and morbidity
Isolated hypercholesterolemia use bile acid binding resins, may worsen hypertriglycermka
Nicotinic acid - good LDL and triglyceride lowering effect, increase HDL (adverse effect many)
Ezetimibe. - well tolerated
Fibrates - only if previous drugs not well tolerated